Issue Brief
  1. See generally Congressional Research Service (CRS), Midnight Rulemaking:  Background and Options for Congress (Oct. 4, 2016), https://fas.org/sgp/crs/misc/R42612.pdf.

    ← Return to text

  2. 5 U.S.C. § § 551-559.

    ← Return to text

  3. 5 U.S.C. § 553; see also CRS, The Federal Rulemaking Process:  An Overview at 5-6 (June 17, 2013), https://fas.org/sgp/crs/misc/RL32240.pdf.

    ← Return to text

  4. CRS, The Federal Rulemaking Process:  An Overview, supra. note 3 at 6.

    ← Return to text

  5. CRS, The Congressional Review Act:  Frequently Asked Questions at 8 (updated Jan. 14, 2020) (citing 5 U.S.C. § 553 (b)(B)), https://fas.org/sgp/crs/misc/R43992.pdf; see generally CRS, The Federal Rulemaking Process:  An Overview, supra. note 3.

    ← Return to text

  6. CRS, Midnight Rulemaking:  Background and Options for Congress, supra. note 1 at 6.

    ← Return to text

  7. For historical use of the latter, see CRS, The Federal Rulemaking Process:  An Overview, supra. note 3.

    ← Return to text

  8. This brief is a general overview and is not intended to be an exhaustive explanation of all technical issues and exceptions.

    ← Return to text

  9. 5 U.S.C. § § 801-808.

    ← Return to text

  10. 5 U.S.C. § 802 (a); see also CRS, Disapproval of Regulations by Congress:  Procedure Under the Congressional Review Act (Oct. 10, 2001). Regulations subject to the CRA that took effect before Congress disapproved them are “retroactively negated.” CRS, The Congressional Review Act:  Frequently Asked Questions, supra. note 1, at Summary page.

    ← Return to text

  11. The regulations also must be submitted to the Comptroller General (Government Accountability Office). 5 U.S.C. § 801 (a)(1).

    ← Return to text

  12. Excluding days either chamber is adjourned for more than 3 days during a session. 5 U.S.C. § 802 (a).

    ← Return to text

  13. Id. at 1.

    ← Return to text

  14. If an agency does not report an action to Congress as a rule, Congress can ask the GAO for an opinion about whether the CRA applies to that action. CRS, The Congressional Review Act:  Frequently Asked Questions, supra. note 1, at 12.

    ← Return to text

  15. Id. at 7-8.

    ← Return to text

  16. Id. at 8.

    ← Return to text

  17. Daniel R. Perez, George Washington Regulatory Studies Center, Upcoming CRA Deadline has Implications for Regulatory Oversight by Congress (Dec. 11, 2019), https://regulatorystudies.columbian.gwu.edu/upcoming-cra-deadline-has-implications-regulatory-oversight-congress.

    ← Return to text

  18. See generally Curtis W. Copeland and Richard S. Beth, CRS, Congressional Review Act:  Disapproval of Rules in a Subsequent Session of Congress (updated Sept. 3, 2008), https://fas.org/sgp/crs/misc/RL34633.pdf.

    ← Return to text

  19. George Washington University Regulatory Studies Center, Congressional Review Act (last accessed Jan. 19, 2021), https://regulatorystudies.columbian.gwu.edu/congressional-review-act.

    ← Return to text

  20. 5 U.S.C. § 801 (b)(2).

    ← Return to text

  21. CRS, The Congressional Review Act:  Frequently Asked Questions, supra. note 1, at 14.

    ← Return to text

  22. Daniel R. Perez, George Washington University Regulatory Studies Center, Upcoming CRA Deadline has Implications for Regulatory Oversight by Congress, supra. note 22.

    ← Return to text

  23. Subsequently, the CRA was used to nullify a Bureau of Consumer Financial Protection rule in May 2018. For a list of all rules nullified by a CRA joint resolution of disapproval to date, see U.S. Gov’t Accountability Office, Congressional Review Act, FAQs, What congressional resolutions of disapproval have occurred under the CRA? (last accessed Jan. 19, 2021), https://www.gao.gov/legal/other-legal-work/congressional-review-act.

    ← Return to text

  24. Id.

    ← Return to text

  25. Id.

    ← Return to text

  26. 5 U.S.C. § 805.

    ← Return to text

  27. CRS, The Congressional Review Act:  Frequently Asked Questions, supra. note 1, at 20-21.

    ← Return to text

  28. Id. at 21-23.

    ← Return to text

  29. Ronald A. Klain, Assistant to the President and Chief of Staff, Memorandum for the Heads of Executive Departments and Agencies (Jan. 20, 2021) (Fed. Reg. publication forthcoming), https://www.whitehouse.gov/briefing-room/presidential-actions/2021/01/20/regulatory-freeze-pending-review/.

    ← Return to text

  30. All actions under this memorandum are subject to exceptions allowed by OMB for emergencies or other urgent circumstances related to health, safety, environmental, financial, or national security matters. Rules subject to statutory or judicial deadlines also are exempt. Id. at ¶ ¶ 1, 4.

    ← Return to text

  31. Id. at ¶ 2.

    ← Return to text

  32. Id. at ¶ 3.

    ← Return to text

  33. Id.

    ← Return to text

  34. Id.

    ← Return to text

  35. Id. at ¶ 6.

    ← Return to text

  36. For additional information, see KFF, The Trump Administration’s Final Rule on Section 1557 Non-Discrimination Regulations Under the ACA and Current Status (Sept. 2020), https://www.kff.org/racial-equity-and-health-policy/issue-brief/the-trump-administrations-final-rule-on-section-1557-non-discrimination-regulations-under-the-aca-and-current-status/.

    ← Return to text

  37. President Joseph R. Biden, Jr., Executive Order on Preventing and Combatting Discrimination on the Basis of Gender Identity or Sexual Orientation (Jan. 20, 2021) , https://www.whitehouse.gov/briefing-room/presidential-actions/2021/01/20/executive-order-preventing-and-combating-discrimination-on-basis-of-gender-identity-or-sexual-orientation/.

    ← Return to text

  38. Id. at § 2.

    ← Return to text

  39. When revising the Section 1557 regulations, the Trump Administration also eliminated explicit nondiscrimination protections related to gender identity and sexual orientation in 10 other HHS regulations that govern Medicaid managed care entities, state Medicaid programs, PACE organizations, group and individual health insurance issuers, Marketplaces, qualified health plan issuers, agents and brokers that assist with Marketplace applications and enrollment, and education programs that receive federal financial assistance. KFF, The Trump Administration’s Final Rule on Section 1557 Non-Discrimination Regulations Under the ACA and Current Status, supra. note 36.

    ← Return to text

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.